FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 29.32

Change

-0.26 (-0.88)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-21 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

-3.37 (-2.52%)

USD 16.21B
VOT Vanguard Mid-Cap Growth Index ..

-5.82 (-2.15%)

USD 14.12B
IJK iShares S&P Mid-Cap 400 Growth..

-2.23 (-2.48%)

USD 8.83B
XMMO Invesco S&P MidCap Momentum ET..

-2.80 (-2.23%)

USD 3.81B
IVOG Vanguard S&P Mid-Cap 400 Growt..

-2.59 (-2.32%)

USD 0.98B
ETHO Amplify ETF Trust

-1.54 (-2.65%)

USD 0.18B
CWS AdvisorShares Focused Equity E..

-1.08 (-1.58%)

USD 0.17B
BFOR Barron's 400 ETF

-1.40 (-1.87%)

USD 0.14B
IPO Renaissance IPO ETF

-1.01 (-2.31%)

USD 0.12B
PEXL Pacer US Export Leaders ETF

-0.89 (-1.80%)

USD 0.04B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.55% 81% B- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.55% 81% B- 69% C-
Trailing 12 Months  
Capital Gain 5.20% 56% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.20% 56% F 54% F
Trailing 5 Years  
Capital Gain -7.51% 6% D- 28% F
Dividend Return 2.70% 17% F 6% D-
Total Return -4.81% 6% D- 16% F
Average Annual (5 Year Horizon)  
Capital Gain -4.41% 17% F 17% F
Dividend Return -3.73% 17% F 12% F
Total Return 0.69% 61% D- 17% F
Risk Return Profile  
Volatility (Standard Deviation) 26.44% 17% F 36% F
Risk Adjusted Return -14.09% 17% F 15% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.